Deferasirox
SUPELCO/Y0002196 - CRS, European Pharmacopoeia (EP) Reference Standard
Synonym: 4-
CAS Number: 201530-41-8
Empirical Formula (Hill Notation): C21H15N3O4
Molecular Weight: 373.36
MDL Number: MFCD09951804
Linear Formula: C21H15N3O4
Product Type: Chemical
InChI | 1S/C21H15N3O4/c25-17-7-3- |
InChI key | FMSOAWSKCWYLBB-VBGLAJCLSA |
manufacturer/tradename | EDQM |
storage temp. | 2-8°C |
Biochem/physiol Actions: | Deferasirox is an orally available iron chelator used clinically for reduction of chronic iron overload in diseases such as β-thalassemia. |
General description: | This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia.For further information and support please go to the website of the issuing Pharmacopoeia . |
Other Notes: | Sales restrictions may apply. |
Packaging: | Unit quantity: 70 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity, please visit the EDQM reference substance catalogue . |
Symbol | GHS07,GHS09 |
Signal word | Warning |
Hazard statements | H302 - H400 |
Precautionary statements | P264 - P270 - P273 - P301 + P312 - P391 - P501 |
WGK Germany | WGK 3 |
Flash Point(F) | Not applicable |
Flash Point(C) | Not applicable |
Storage Temp. | 2-8°C |
UNSPSC | 41116107 |